A
786.32
4.60 (0.59%)
| Penutupan Terdahulu | 781.72 |
| Buka | 782.06 |
| Jumlah Dagangan | 116,570 |
| Purata Dagangan (3B) | 343,879 |
| Modal Pasaran | 49,141,043,200 |
| Harga / Pendapatan (P/E TTM) | 40.26 |
| Harga / Pendapatan (P/E Ke hadapan) | 29.50 |
| Harga / Jualan (P/S) | 11.11 |
| Harga / Buku (P/B) | 6.64 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 7 May 2026 |
| Margin Keuntungan | 40.26% |
| Margin Operasi (TTM) | 17.50% |
| EPS Cair (TTM) | 16.39 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 95.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 0.71% |
| Nisbah Semasa (MRQ) | 7.29 |
| Aliran Tunai Operasi (OCF TTM) | -82.75 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -143.39 M |
| Pulangan Atas Aset (ROA TTM) | -0.21% |
| Pulangan Atas Ekuiti (ROE TTM) | 17.36% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | argenx SE | Menurun | Menaik |
AISkor Stockmoo
0.1
| Konsensus Penganalisis | 2.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -1.0 |
| Purata | 0.13 |
|
Argenx is a Dutch company focused on using its antibody engineering technology to treat rare autoimmune diseases. Vyvgart (efgartigimod) was initially approved in the US in December 2021 as a treatment for generalized myasthenia gravis, followed by approvals in Europe and Japan in 2022. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Institusi | 55.54% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 1,247.00 (Wells Fargo, 58.59%) | Beli |
| Median | 944.00 (20.05%) | |
| Rendah | 867.00 (Baird, 10.26%) | Pegang |
| Purata | 1,001.14 (27.32%) | |
| Jumlah | 6 Beli, 1 Pegang | |
| Harga Purata @ Panggilan | 763.13 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Wedbush | 09 Mar 2026 | 1,000.00 (27.17%) | Beli | 740.40 |
| Baird | 27 Feb 2026 | 867.00 (10.26%) | Pegang | 766.92 |
| Citizens | 27 Feb 2026 | 944.00 (20.05%) | Beli | 766.92 |
| Guggenheim | 27 Feb 2026 | 1,120.00 (42.44%) | Beli | 766.92 |
| HC Wainwright & Co. | 27 Feb 2026 | 940.00 (19.54%) | Beli | 766.92 |
| RBC Capital | 27 Feb 2026 | 890.00 (13.19%) | Beli | 766.92 |
| Wells Fargo | 27 Feb 2026 | 1,247.00 (58.59%) | Beli | 766.92 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |